rossjohn.bsky.social
@rossjohn.bsky.social
Prof. Jamie Rossjohn FAA FRS
Monash University
Monash University
Reposted by rossjohn.bsky.social
CD1d remodels the tumor-infiltrating myeloid populations controlling anti-tumor immunity. From Lauren Evans, Maria Conde Poole, Patricia Barral @barrallab.bsky.social: rupress.org/jem/article/...
Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 9, 2026 at 12:01 AM
CD1d remodels the tumor-infiltrating myeloid populations controlling anti-tumor immunity. From Lauren Evans, Maria Conde Poole, Patricia Barral @barrallab.bsky.social: rupress.org/jem/article/...
Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
Reposted by rossjohn.bsky.social
Some substantial changes announced by ARC for next (supposedly final) rounds of some schemes, esp. Discovery Projects👇
🔹CIs can only be on one DP28 app
🔹CIs on successful DP26 or DP27 apps cannot apply
🔹Rejoinder process “has been removed and replaced with more detailed feedback to applicants” ⁉️
🔹CIs can only be on one DP28 app
🔹CIs on successful DP26 or DP27 apps cannot apply
🔹Rejoinder process “has been removed and replaced with more detailed feedback to applicants” ⁉️
www.arc.gov.au
August 18, 2026 at 5:42 AM
Some substantial changes announced by ARC for next (supposedly final) rounds of some schemes, esp. Discovery Projects👇
🔹CIs can only be on one DP28 app
🔹CIs on successful DP26 or DP27 apps cannot apply
🔹Rejoinder process “has been removed and replaced with more detailed feedback to applicants” ⁉️
🔹CIs can only be on one DP28 app
🔹CIs on successful DP26 or DP27 apps cannot apply
🔹Rejoinder process “has been removed and replaced with more detailed feedback to applicants” ⁉️